Published in Gene Therapy Weekly, December 19th, 2002
According to Kristiina Tyynela and colleagues, they placed eight different groups of rats on eight different treatment protocols comprising ad/tk, ganciclovir (GCV), adv-mediated macrophage colony-stimulating factor (adv/MCSF) or no treatment at all. They...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.